EU supports biotech company in Austria with EUR 24 million for antifungal research and innovation

noviembre 22, 2018

AKETXE Consulting

Horizon 2020

News

EU supports biotech company in Austria with EUR 24 million for antifungal research and innovation

Thursday, 22 November, 2018

The European Investment Bank (EIB) is lending EUR 24 million to F2G Biotech, a research-intensive company in Austria, focusing on the discovery and development of novel drugs to treat life threatening fungal diseases.

Read full text

Horizon 2020
Enlace: EU supports biotech company in Austria with EUR 24 million for antifungal research and innovation

EU supports biotech company in Austria with EUR 24 million for antifungal research and innovation

EU supports biotech company in Austria with EUR 24 million for antifungal research and innovation

Síguenos en las redes sociales

Última entrada del blog

Uso de cookies